CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of ... CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Show more
LOS ANGELES, Sept. 03, 2024 (GLOBE NEWSWIRE) -- via IBN β IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0049 | 4.4104410441 | 0.1111 | 0.1373 | 0.1081 | 11744460 | 0.12481286 | CS |
4 | -0.008 | -6.45161290323 | 0.124 | 0.3699 | 0.1 | 40171159 | 0.13870153 | CS |
12 | -0.0597 | -33.9783722254 | 0.1757 | 0.3699 | 0.1 | 14650529 | 0.1394633 | CS |
26 | -10.264 | -98.8824662813 | 10.38 | 16 | 0.0955 | 9499586 | 0.47889346 | CS |
52 | -86.884 | -99.8666666667 | 87 | 137.5 | 0.0955 | 4978274 | 1.15187761 | CS |
156 | -1814.884 | -99.9936088154 | 1815 | 2220 | 0.0955 | 2242781 | 97.68511911 | CS |
260 | -6359.884 | -99.9981761006 | 6360 | 8534.85 | 0.0955 | 1550522 | 593.86803518 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.